Christoph Hämmerle

Title: Christoph Hämmerle: Innovator in Oral Disease Treatment

Introduction

Christoph Hämmerle is a notable inventor based in Benglen, Switzerland. He has made significant contributions to the field of oral health through his innovative research and development of compositions aimed at treating oral diseases.

Latest Patents

Hämmerle holds a patent for a composition comprising self-assembling peptides for use in the treatment of gingivitis, periodontitis, and/or peri-implantitis. This invention provides a composition that includes specific self-assembling peptides capable of self-assembly at a pH below 7.5 and at least physiologic ionic strength. The composition is designed to treat oral diseases by filling pockets formed adjacent to teeth, thereby enhancing tissue regeneration. Additionally, it may be suitable for the controlled release of active agents, such as antimicrobial or antibiotic agents.

Career Highlights

Throughout his career, Christoph Hämmerle has worked with various companies, including Credentis AG and Naviswiss AG. His experience in these organizations has contributed to his expertise in developing innovative solutions for oral health challenges.

Collaborations

Hämmerle has collaborated with notable individuals in his field, including Michael Hug and Dominikus Amadeus Lysek. These partnerships have furthered his research and development efforts.

Conclusion

Christoph Hämmerle's contributions to the field of oral health through his innovative patents and collaborations highlight his commitment to improving treatment options for oral diseases. His work continues to influence advancements in dental care.